• Completed fundraising activities during the December quarter
• Continued focus on business development opportunities for seaweed and bird's nest businesses
• Renewed R&D consultancy agreement and entered into outsourcing R&D agreement

BPH Global Limited (ASX: BP8), a plant-based biotechnology company, released its Appendix 4C and Quarterly Activities Report for the period ended 31 December 2024. During the quarter, the company continued to engage with prospective investors, completing several fundraising activities, including a $100,000 investment from Mr Rajiv Ramnarayan and a $125,000 placement to Australian-based investors. The company also raised $100,000 through the issue of convertible notes to a Malaysian-based investor. BPH Global ended the quarter with cash of approximately $0.226 million. The company continued to focus on business development opportunities for its seaweed and bird's nest businesses. Key highlights include the completion of the Indonesian seaweed project transaction, the renewal of a consultancy agreement with Gaia Mariculture Pte Ltd to manage the company's R&D programs, and the entry into an outsourcing R&D agreement with TP Innovation Holdings Pte Ltd on behalf of Temasek Polytechnic in Singapore. The company also continues to recognize the importance of securing the supply of quality bird's nest products at competitive prices to support its goal of growing its bird's nest sales.